Cordium Pharmaceuticals Pvt Ltd is a trusted global exporter of Trastuzumab Biosimilar 150mg Injection from India, delivering high-quality, cost-effective oncology biologics to international healthcare markets including the United States, United Kingdom, Germany, Netherlands, South Africa, United Arab Emirates, and Brazil.
We ensure WHO-GMP compliant manufacturing standards, stringent quality control, and fast international delivery support for hospitals, distributors, and healthcare procurement agencies worldwide.
š What is Trastuzumab Biosimilar 150mg Injection?
Trastuzumab Biosimilar is a monoclonal antibody used in targeted cancer therapy, primarily for HER2-positive breast cancer and gastric cancer treatment. It works by blocking HER2 receptors, slowing or stopping the growth of cancer cells.
š Usage / Indications
Trastuzumab Biosimilar 150mg Injection is prescribed for:
HER2-positive breast cancer (early and metastatic stages)
HER2-overexpressing gastric or gastroesophageal junction cancer
Adjuvant and neoadjuvant cancer therapy (as recommended by oncologists)
š Dosage Information
Administered intravenously under strict medical supervision
Dosage is individualized based on patient condition, body weight, and treatment protocol
Common regimen includes an initial loading dose followed by maintenance doses every 1ā3 weeks as directed by an oncologist
Must only be used in hospital or clinical oncology settings
ā ļø Side Effects
Possible side effects may include:
Fever and chills during infusion
Nausea, vomiting, or fatigue
Headache or dizziness
Diarrhea
Heart-related effects (rare but serious ā requires monitoring)
Infusion-related reactions
Note: Continuous cardiac monitoring is recommended during treatment as advised by healthcare professionals.
š Global Export & Supply Advantage
Cordium Pharmaceuticals Pvt Ltd ensures:
Fast international shipping & export documentation support
Reliable supply chain for oncology biologics
Bulk supply for hospitals & distributors
Compliance with global pharmaceutical standards
Secure packaging & temperature-controlled logistics
š Contact for Export Inquiry
š± WhatsApp: +91-9405117673
š§ Email: info@cordiumpharma.com
We welcome global B2B partnerships for oncology pharmaceutical distribution and supply contracts.
We ensure WHO-GMP compliant manufacturing standards, stringent quality control, and fast international delivery support for hospitals, distributors, and healthcare procurement agencies worldwide.
š What is Trastuzumab Biosimilar 150mg Injection?
Trastuzumab Biosimilar is a monoclonal antibody used in targeted cancer therapy, primarily for HER2-positive breast cancer and gastric cancer treatment. It works by blocking HER2 receptors, slowing or stopping the growth of cancer cells.
š Usage / Indications
Trastuzumab Biosimilar 150mg Injection is prescribed for:
HER2-positive breast cancer (early and metastatic stages)
HER2-overexpressing gastric or gastroesophageal junction cancer
Adjuvant and neoadjuvant cancer therapy (as recommended by oncologists)
š Dosage Information
Administered intravenously under strict medical supervision
Dosage is individualized based on patient condition, body weight, and treatment protocol
Common regimen includes an initial loading dose followed by maintenance doses every 1ā3 weeks as directed by an oncologist
Must only be used in hospital or clinical oncology settings
ā ļø Side Effects
Possible side effects may include:
Fever and chills during infusion
Nausea, vomiting, or fatigue
Headache or dizziness
Diarrhea
Heart-related effects (rare but serious ā requires monitoring)
Infusion-related reactions
Note: Continuous cardiac monitoring is recommended during treatment as advised by healthcare professionals.
š Global Export & Supply Advantage
Cordium Pharmaceuticals Pvt Ltd ensures:
Fast international shipping & export documentation support
Reliable supply chain for oncology biologics
Bulk supply for hospitals & distributors
Compliance with global pharmaceutical standards
Secure packaging & temperature-controlled logistics
š Contact for Export Inquiry
š± WhatsApp: +91-9405117673
š§ Email: info@cordiumpharma.com
We welcome global B2B partnerships for oncology pharmaceutical distribution and supply contracts.
Keywords
